ArticleJournal for immunotherapy of cancer2022

System analysis based on the cancer-immunity cycle identifies ZNF207 as a novel immunotherapy target for hepatocellular carcinoma.

Xu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.